REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $718,920 | -1.1% | 7,051 | -11.8% | 0.00% | -100.0% |
Q1 2023 | $726,633 | +133.3% | 7,992 | -2.5% | 0.00% | – |
Q4 2022 | $311,480 | +39.1% | 8,199 | +11.2% | 0.00% | – |
Q2 2022 | $224,000 | -80.9% | 7,371 | -36.6% | 0.00% | -100.0% |
Q3 2021 | $1,170,000 | -27.5% | 11,622 | +1.9% | 0.00% | 0.0% |
Q2 2021 | $1,613,000 | +79.4% | 11,401 | +26.5% | 0.00% | 0.0% |
Q1 2021 | $899,000 | -16.4% | 9,015 | +3.5% | 0.00% | 0.0% |
Q4 2020 | $1,076,000 | +26.7% | 8,709 | -0.1% | 0.00% | 0.0% |
Q3 2020 | $849,000 | -60.9% | 8,714 | -37.5% | 0.00% | -50.0% |
Q2 2020 | $2,174,000 | +42.5% | 13,935 | +31.8% | 0.00% | 0.0% |
Q1 2020 | $1,526,000 | -16.1% | 10,575 | +18.8% | 0.00% | 0.0% |
Q4 2019 | $1,819,000 | +169.1% | 8,900 | +5.7% | 0.00% | +100.0% |
Q3 2019 | $676,000 | -13.2% | 8,424 | +2.0% | 0.00% | 0.0% |
Q2 2019 | $779,000 | +24.4% | 8,256 | +12.8% | 0.00% | 0.0% |
Q1 2019 | $626,000 | +149.4% | 7,319 | +138.5% | 0.00% | – |
Q3 2018 | $251,000 | – | 3,069 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |